NCT Number: NCT05804318
Phase: Not Applicable
Trial Summary: This trial is a prospective, single-arm, multi-center clinical trial designed to assess whether adaptive radiotherapy with urethral sparing for low to intermediate risk localized prostate cancer will – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): Varian, a Siemens Healthineers Company
Acronym: ARTIA-Prostate
Daily Adaptive Radiation Therapy Using an Individualized Approach for Prostate Cancer
— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives